Replies to post #32959 on Biotech Values

[Democritus_of_Abdera]

I wonder if PD-1 ligands could be a first line defense against the cytokine surge that causes so much morbidity in an influenza pandemic?

What biotech companies have PD-1 relevant drugs in their pipe-line? Not just inhibitors, but also possible short-term activators?